克罗恩病治疗和记忆T细胞子集的变化:从病例系列的见解
Zhi-Hui Chen1,2, Ying-Ying Tang3, Si-Yuan Sheng3
1Department of Gastrointestinal Surgery Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Translational gastroenterology and hepatology
|May 8, 2024
概括
克罗恩病的治疗改变了记忆T细胞子集,影响了免疫反应. 调节这些T细胞子集为免疫相关疾病提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
背景情况:
- 克罗恩氏病 (CD) 是一种慢性炎症性肠病,影响全球数百万人.
- 了解免疫反应,特别是记忆T细胞子集,CD治疗后对治疗进展至关重要.
- 在接受治疗的CD患者中,记忆T细胞子集的特定功能仍未得到充分探索.
研究的目的:
- 研究当前治疗对克罗恩病患者内存T细胞子集的影响.
- 分析抗炎或免疫抑制治疗后T细胞子集的功能变化.
- 在T细胞群体内确定潜在的治疗点,以控制CD.
主要方法:
- 在使用流细胞计测的8名接受治疗的CD患者和健康捐赠者的T细胞表型和细胞因子生产分析.
- 从血液和介质淋巴结 (MLN) 中分离周围血液单核细胞 (PBMC) 和淋巴细胞.
- 在CD患者和健康对照者之间对T细胞子集频率和功能的统计比较.
主要成果:
- 接受治疗的CD患者显示T细胞分布发生变化,包括PBMC中增加的CD8+T细胞和MLN中修改的CD4+/CD8+T细胞.
- 记忆T细胞表现出干扰素-γ (IFN-γ) 和瘤坏死因子-α (TNF-α) 的产生减少.
- 在CD患者的MLN中观察到IFN-γ产生CD8+干细胞类T记忆细胞 (Tscm) 的显著变化.
结论:
- 对CD的疗法显著影响记忆T细胞子集的频率和功能.
- 调节记忆T细胞反应为免疫相关疾病提供了一个有前途的治疗策略.
- 需要进一步的临床研究,以充分阐明针对CD中T细胞子集的治疗潜力.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158
Inflammatory Bowel Disease II: Crohn's Disease
219
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
219
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Cells of the Adaptive Immune Response
980
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
980
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331


